Optimer Pharmaceuticals, Inc. (OPTR)

[surf1944]

8:03AM Optimer Pharma's DIFICID tablets approved by Health Canada for the Treatment of clostridium difficile infection and now available to Canadian patients (OPTR) 16.15 : Co announced that DIFICID tablets were approved by Health Canada for the treatment of Clostridium difficile infection in adults 18 years of age and older and that DIFICID is now available to treat patients in Canada. The approval was based on Health Canada's evaluation of two large, multi-national, Phase 3 clinical trials demonstrating that DIFICID was as effective as oral vancomycin in providing an initial clinical response and was superior in providing a sustained clinical response for 28 days post treatment. DIFICID is the first new treatment for CDI to be approved in Canada in over 20 years.